Park West Asset Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,370,000
| Closed | -$8.73M | – | 63 |
|
|
2019
Q4 | $8.73M | Buy |
3,370,000
+120,000
| +4% | +$311K | 0.37% | 56 |
|
|
2019
Q3 | $10.3M | Buy |
3,250,000
+250,000
| +8% | +$790K | 0.5% | 45 |
|
|
2019
Q2 | $10.1M | Sell |
3,000,000
-495,615
| -14% | -$1.67M | 0.42% | 53 |
|
|
2019
Q1 | $10.7M | Hold |
3,495,615
| – | – | 0.47% | 46 |
|
|
2018
Q4 | $5.45M | Buy |
3,495,615
+53,450
| +2% | +$83.4K | 0.27% | 64 |
|
|
2018
Q3 | $9.4M | Buy |
3,442,165
+500,000
| +17% | +$1.36M | 0.34% | 56 |
|
|
2018
Q2 | $7.71M | Sell |
2,942,165
-72,200
| -2% | -$189K | 0.29% | 66 |
|
|
2018
Q1 | $8.32M | Buy |
3,014,365
+301,507
| +11% | +$832K | 0.37% | 58 |
|
|
2017
Q4 | $8.74M | Sell |
2,712,858
-160,702
| -6% | -$517K | 0.4% | 54 |
|
|
2017
Q3 | $11.9M | Sell |
2,873,560
-429,267
| -13% | -$1.78M | 0.71% | 35 |
|
|
2017
Q2 | $17.6M | Buy |
3,302,827
+340,737
| +12% | +$1.81M | 0.97% | 36 |
|
|
2017
Q1 | $17M | Buy |
2,962,090
+1,462,090
| +97% | +$8.39M | 0.99% | 36 |
|
|
2016
Q4 | $5.94M | Buy |
+1,500,000
| New | +$5.94M | 0.46% | 42 |
|